Therapy for alcoholic liver disease

Area of Science:

• Hepatology
• Gastroenterology
• Addiction Medicine

Background:

• Alcoholism causes significant global mortality, with alcoholic liver disease (ALD) being a primary driver.
• ALD encompasses alcoholic steatosis, hepatitis, and cirrhosis, representing a spectrum of liver damage.
• Established scoring systems like Child-Pugh and MELD aid in assessing ALD severity and guiding treatment decisions.

Purpose of the Study:

• To review the current understanding and management strategies for alcoholic liver disease.
• To highlight the importance of abstinence and available therapeutic interventions.
• To discuss complications and advanced treatment options for ALD.

Main Methods:

• Literature review of alcoholism and alcoholic liver disease.
• Analysis of therapeutic approaches including abstinence, psychotherapy, pharmacotherapy, and nutritional support.
• Examination of diagnostic scoring systems and management of ALD complications.

Main Results:

• Abstinence is the cornerstone of ALD therapy, supported by various psychotherapies.
• Pharmacotherapies like disulfiram, naltrexone, acamprosate, and baclofen aid in reducing alcohol consumption.
• Nutritional therapy is crucial for addressing deficiencies and muscle wasting, with revised protein intake recommendations.
• Corticosteroids and pentoxifylline are used for severe alcoholic hepatitis, though mortality benefits require further evidence.
• Advanced ALD complications include ascites, hepatic encephalopathy, and increased risk of hepatomas.

Conclusions:

• Effective management of alcoholic liver disease relies on a multi-faceted approach including abstinence, tailored therapies, and nutritional support.
• Liver transplantation offers a viable option for severe ALD, contingent upon sustained abstinence.
• Continued research is needed to solidify the efficacy of certain treatments in reducing ALD-related mortality.